Shockless IMPLant Evaluation | Clinical Trial - SIMPLE


The goal of the trial was to assess the safety and efficacy of no defibrillation threshold (DFT) testing in patients receiving an implantable cardioverter-defibrillator (ICD) implantation.

Contribution to the Literature: The SIMPLE trial suggests that routine DFT testing may no longer be necessary at the time of implantation for contemporary ICD devices.